Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
85.90
+0.21 (0.25%)
At close: Oct 12, 2026, 4:00 PM EDT
86.29
+0.39 (0.45%)
After-hours: Oct 12, 2026, 7:30 PM EDT
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $8.03 billion as of October 12, 2026. It is the 2,572nd most valuable company in the world and the 870th biggest in the United States. Its market cap has increased by 651.71% in one year.
Market Cap
8.03B
Enterprise Value
6.88B
1-Year Change
651.71%
Global Rank
Country Rank
#870 United States
Category
ChartMarket Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $8.03B, an increase of 7,086.69%. That is a compound annual growth rate of 50.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 7.56B | 197.24% |
| Dec 31, 2025 | 2.54B | 112.30% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
| Apr 7, 2016 | 111.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 9.35B |
| Protagonist Therapeutics | 9.30B |
| Arrowhead Pharmaceuticals | 8.86B |
| Axsome Therapeutics | 8.82B |
| Cytokinetics | 8.75B |
| Caris Life Sciences | 8.39B |
| TG Therapeutics | 7.85B |
| ABIVAX Société Anonyme | 7.71B |